Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

TIMELY ESCALATION OF MECHANICAL CIRCULATORY SUPPORT AND INTER-CENTER COLLABORATION: THE KEY TO A SUCCESSFUL OUTCOME IN ADVANCED CARDIOGENIC SHOCK

Caldarella Yasmine Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso | Menegon Vittoria Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso | Barbisan Davide Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso | Cocuzza Federica Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso | Sciarretta Tommaso Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso | Malasisi Michele Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso | Tarzia Vincenzo Padova (Padova) – Cardiosurgery Clinic, Dpt Of Cardio-Thoracic And Vascular Sciences And Pubblic Health, University Of Padova, Padova, Italia | Gerosa Gino Padova (Padova) – Cardiosurgery Clinic, Dpt Of Cardio-Thoracic And Vascular Sciences And Pubblic Health, University Of Padova, Padova, Italia | Minniti Giuseppe Treviso (Treviso) – Unit Of Cardiosurgery, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso, Treviso, Italia | Cernetti Carlo Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso, Treviso, Italia | Gasparetto Nicola Treviso (Treviso) – Unit Of Cardiology, Neuro-Cardio-Vascular Dpt, Aulss 2 Marca Trevigiana, Hospital Of Treviso, Treviso, Italia

Cardiogenic shock remains a major clinical challenge, requiring timely recognition and intervention. Optimal management involves escalation of mechanical circulatory support (MCS), ideally within an organized hub-and-spoke network. We report the case of a 68-year-old man with ischemic heart disease due to complex coronary artery disease, with multiple percutaneous coronary interventions (PCI) of the left anterior descending artery (LAD), complicated by recurrent in-stent restenosis. In August 2025, recurrent angina led to the diagnosis of severe left main in-stent restenosis, for which surgical revascularization was attempted. Only a left internal mammary artery graft to the LAD could be performed because circumflex revascularization was not feasible. The postoperative course was complicated by cardiogenic shock, requiring urgent PCI of the left main and circumflex arteries. After initial recovery, the patient was readmitted in October 2025 from the cardiac rehabilitation ward with SCAI D cardiogenic shock, presenting with moderate left ventricular dysfunction, severe mitral regurgitation, profound hypotension and hypoperfusion resulting in hepatorenal dysfunction, secondary to acute occlusion of the LAD bypass graft. Early initiation of inotropic and vasopressor therapy combined with intra-aortic balloon pump implantation achieved partial hemodynamic stabilization. Owing to persistent instability the patient was promptly transferred to a tertiary hub center with a heart transplant program, where escalation to left ventricular unloading with Impella 5.5 resulted in marked hemodynamic improvement and recovery of end-organ function. This stabilization allowed comprehensive reassessment and planning of definitive therapy. The patient was subsequently transferred back to the referring center after 19 days of MCS and underwent successful bypass grafting to the LAD and mitral valve replacement. This case highlights the critical role of structured collaboration between centers in managing advanced cardiogenic shock. Timely escalation of mechanical circulatory support, including Impella 5.5, enables hemodynamic stabilization and effective left ventricular unloading, creating a window for comprehensive reassessment and planning of definitive therapies. Hub-and-spoke networks are therefore essential to optimize outcomes in patients with SCAI D cardiogenic shock, ensuring access to advanced therapies, including heart transplantation, when recovery is not achievable.